Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Edoardo Schneider"'
Autor:
Sara G. Romeo, Ilaria Secco, Edoardo Schneider, Christina M. Reumiller, Celio X. C. Santos, Anna Zoccarato, Vishal Musale, Aman Pooni, Xiaoke Yin, Konstantinos Theofilatos, Silvia Cellone Trevelin, Lingfang Zeng, Giovanni E. Mann, Varun Pathak, Kevin Harkin, Alan W. Stitt, Reinhold J. Medina, Andriana Margariti, Manuel Mayr, Ajay M. Shah, Mauro Giacca, Anna Zampetaki
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-18 (2023)
Abstract The microvasculature plays a key role in tissue perfusion and exchange of gases and metabolites. In this study we use human blood vessel organoids (BVOs) as a model of the microvasculature. BVOs fully recapitulate key features of the human m
Externí odkaz:
https://doaj.org/article/353954422197417aa51e7b271e88c1e2
Autor:
Ambra Cappelletto, Harriet E. Allan, Marilena Crescente, Edoardo Schneider, Rossana Bussani, Hashim Ali, Ilaria Secco, Simone Vodret, Roberto Simeone, Luca Mascaretti, Serena Zacchigna, Timothy D. Warner, Mauro Giacca
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2023)
Thrombosis of the lung microvasculature is a characteristic of COVID-19 disease, which is observed in large excess compared to other forms of acute respiratory distress syndrome and thus suggests a trigger for thrombosis that is endogenous to the lun
Externí odkaz:
https://doaj.org/article/4d9c6b235b4c46048734a1b26cae79e3
Autor:
Marco Metra, Rossana Bussani, Alessia Paldino, Fulvio Silvestri, Serena Zacchigna, Chiara Collesi, Mauro Giacca, Marco Merlo, Matteo Dal Ferro, Ricardo Correa, Gianfranco Sinagra, Edoardo Schneider, Lorena Zentilin, Vincenzo Nuzzi
Publikováno v:
Clinical Research in Cardiology
Objective Despite growing evidence about myocardial injury in hospitalized COronaVIrus Disease 2019 (COVID-19) patients, the mechanism behind this injury is only poorly understood and little is known about its association with SARS-CoV-2-mediated myo
Autor:
Antonio Mura, Francesca Bortolotti, Giulia Ruozi, Mateusz Tomczyk, Edoardo Schneider, Simone Vodret, Giulio Ciucci, Lorena Zentilin, Mauro Giacca
Publikováno v:
Journal of Molecular and Cellular Cardiology. 173:6-7
Autor:
Ambra Cappelletto, Harriet E. Allan, Marilena Crescente, Edoardo Schneider, Rossana Bussani, Hashim Ali, Ilaria Secco, Simone Vodret, Roberto Simeone, Luca Mascaretti, Serena Zacchigna, Timothy D. Warner, Mauro Giacca
Publikováno v:
Cappelletto, A, Allan, H E, Crescente, M, Schneider, E, Bussani, R, Ali, H, Secco, I, Vodret, S, Mascaretti, L, Zacchigna, S, Warner, T D, Giacca, M & Simeone, R 2022, ' SARS-CoV-2 Spike protein activates TMEM16F-mediated platelet pro-coagulant activity ', Frontiers in Cardiovascular Medicine .
BackgroundThrombosis of the lung micro-vasculature is a characteristic of COVID-19 disease, which is observed in large excess compared to other forms of acute respiratory distress syndrome and thus suggests a trigger for thrombosis endogenous to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43a930feb76bb8ef34f8ab108782cddb
https://doi.org/10.1101/2021.12.14.472668
https://doi.org/10.1101/2021.12.14.472668
Autor:
Mario Milani, Edoardo Schneider, Francesco Bonì, Irene Arduino, Manuela Donalisio, Rafaela Milan Bonotto, David Lembo, Alessandro Marcello, Eloise Mastrangelo
Publikováno v:
Antiviral research
189 (2021). doi:10.1016/j.antiviral.2021.105055
info:cnr-pdr/source/autori:Milani M.; Donalisio M.; Bonotto R.M.; Schneider E.; Arduino I.; Boni F.; Lembo D.; Marcello A.; Mastrangelo E./titolo:Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors/doi:10.1016%2Fj.antiviral.2021.105055/rivista:Antiviral research (Print)/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume:189
Antiviral Research
189 (2021). doi:10.1016/j.antiviral.2021.105055
info:cnr-pdr/source/autori:Milani M.; Donalisio M.; Bonotto R.M.; Schneider E.; Arduino I.; Boni F.; Lembo D.; Marcello A.; Mastrangelo E./titolo:Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors/doi:10.1016%2Fj.antiviral.2021.105055/rivista:Antiviral research (Print)/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume:189
Antiviral Research
The current emergency of the novel coronavirus SARS-CoV2 urged the need for broad-spectrum antiviral drugs as the first line of treatment. Coronaviruses are a large family of viruses that already challenged humanity in at least two other previous out
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b21def4833834663baa0ed52a5acc5c
https://hdl.handle.net/2318/1815508
https://hdl.handle.net/2318/1815508
Autor:
Hashim Ali, Ilaria Secco, Daniel H. Goldhill, Jose M. Jimenez-Guardeño, Luca Braga, Juan Burrone, Giorgia Rizzari, Guilherme Neves, Antonio Cannatà, Edoardo Schneider, Chiara Collesi, Mauro Giacca, Ajay M. Shah, Michael H. Malim, Rebecca Penn, Wendy S. Barclay, Elena Chiavacci, Daniele Arosio, Rossana Bussani, Ana Maria Ortega-Prieto
Publikováno v:
Nature
Nature (Lond.) 594 (2021): 88–93. doi:10.1038/s41586-021-03491-6
info:cnr-pdr/source/autori:Braga L.; Ali H.; Secco I.; Chiavacci E.; Neves G.; Goldhill D.; Penn R.; Jimenez-Guardeno J.M.; Ortega-Prieto A.M.; Bussani R.; Cannata A.; Rizzari G.; Collesi C.; Schneider E.; Arosio D.; Shah A.M.; Barclay W.S.; Malim M.H.; Burrone J.; Giacca M./titolo:Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia/doi:10.1038%2Fs41586-021-03491-6/rivista:Nature (Lond.)/anno:2021/pagina_da:88/pagina_a:93/intervallo_pagine:88–93/volume:594
Nature (Lond.) 594 (2021): 88–93. doi:10.1038/s41586-021-03491-6
info:cnr-pdr/source/autori:Braga L.; Ali H.; Secco I.; Chiavacci E.; Neves G.; Goldhill D.; Penn R.; Jimenez-Guardeno J.M.; Ortega-Prieto A.M.; Bussani R.; Cannata A.; Rizzari G.; Collesi C.; Schneider E.; Arosio D.; Shah A.M.; Barclay W.S.; Malim M.H.; Burrone J.; Giacca M./titolo:Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia/doi:10.1038%2Fs41586-021-03491-6/rivista:Nature (Lond.)/anno:2021/pagina_da:88/pagina_a:93/intervallo_pagine:88–93/volume:594
COVID-19 is a disease with unique characteristics that include lung thrombosis1, frequent diarrhoea2, abnormal activation of the inflammatory response3 and rapid deterioration of lung function consistent with alveolar oedema4. The pathological substr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ee8ef2a9edf1c3b1df8e8a7186d90cf
http://hdl.handle.net/11368/2993737
http://hdl.handle.net/11368/2993737
Autor:
Rafaela Milan Bonotto, Alessandro Marcello, David Lembo, Mario Milani, Eloise Mastrangelo, Manuela Donalisio, Edoardo Schneider, Irene Arduino, Francesco Bonì
The current emergency of the novel coronavirus SARS-CoV-2 urged the need for broad-spectrum antiviral drugs as the first line of treatment. Coronaviruses are a large family of viruses that already challenged humanity in at least two other previous ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf89ddb4302803c1438ba61c313e05af
https://doi.org/10.1101/2020.11.12.379958
https://doi.org/10.1101/2020.11.12.379958
Autor:
Hashim Ali, Ilaria Secco, Luca Braga, Maria Concetta Volpe, Chiara Collesi, Serena Zacchigna, Giorgio Berlot, Fabrizio Zanconati, Andrea Colliva, Lorena Zentilin, Mauro Giacca, Rossana Bussani, Furio Silvestri, Edoardo Schneider
COVID-19 is a deadly pulmonary disease with unique clinical features. A thorough understanding of the molecular and histological correlates of the disease is still missing, especially because post-mortem analysis of COVID-19-affected organs has been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29b7930bbce31b00980fe2a68f6816d5
Autor:
Guido Papa, Oscar R. Burrone, Gianluca Petris, Edoardo Schneider, Luca Braga, Mauro Giacca, Luca Venditti
Publikováno v:
Cell Reports
CRISPR-nucleases have been widely applied for editing cellular and viral genomes, but nuclease-mediated genome editing of double-stranded RNA (dsRNA) viruses has not yet been reported. Here, by engineering CRISPR-Csy4 nuclease to localize to rotaviru